Physician profile
Scott Taylor
NPI 1861542326
$4,918.31
in general payments reported to CMS, 2019-2025
39 companies · $517 in 2025
The $517 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $693 · 2020: $289 · 2021: $630 · 2022: $968 · 2023: $1,196 · 2024: $625 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,332 · Education: $5.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,332.35 |
| Education | $5.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,759.98 | 2019-2025 | Enbrel, Otezla, Otezla |
| Abbvie INC. | $411.55 | 2021-2025 | Vraylar, Qulipta |
| Glaxosmithkline, LLC. | $308.07 | 2019-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $289.49 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $224.75 | 2019-2024 | Jardiance |
| Astrazeneca Pharmaceuticals Lp | $163.83 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Lilly USA, LLC | $161.77 | 2019-2024 | Mounjaro, Jardiance |
| Astellas Pharma US INC | $161.07 | 2019-2025 | Veozah |
| Procept Biorobotics Corporation | $158.72 | 2023 | Aquabeam Robotic System |
| Pfizer INC. | $127.89 | 2019-2021 | |
| Mylan Specialty L.P. | $107.62 | 2019-2023 | Yupelri |
| Penumbra, INC. | $107.46 | 2023 | Indigo System |
| Novartis Pharmaceuticals Corporation | $99.55 | 2022-2023 | |
| Medtronic, INC. | $98.64 | 2023-2024 | Minimed 780g, Intellis Adaptivestim |
| Janssen Pharmaceuticals, INC | $90.74 | 2019-2022 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.